Principal Financial Group’s POINT Biopharma Global Inc. Common Stock PNT Stock Holding History

Principal Financial Group’s Portfolio PNT Stock Details PNT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-30,000	Closed	-$200K	–	2469
2023 Q3	$200K	Buy	30,000 +4,532	+18%	+$37.7K	﹤0.01%	2167
2023 Q2	$231K	Buy	25,468 +423	+2%	+$3.73K	﹤0.01%	2143
2023 Q1	$182K	Sell	25,045 -1,663	-6%	-$12.3K	﹤0.01%	2198
2022 Q4	$195K	Buy	26,708 +16,110	+152%	+$120K	﹤0.01%	2203
2022 Q3	$82K	Sell	10,598 -446	-4%	-$3.79K	﹤0.01%	2366
2022 Q2	$75K	Buy	+11,044	New	+$84.5K	﹤0.01%	2430

Other funds holding PNT

BTI

Blue Trust Inc Alpharetta, Georgia $9.54B AUM 19.86% 1-Year Est. Return

Principal Financial Group's PNT Position: Q4 2023 in Review

Principal Financial Group sold out of POINT Biopharma Global Inc. Common Stock (PNT) in Q4 2023, closing a stake of 30,000 shares — an estimated $200K sold.

Principal Financial Group first reported a position in PNT in Q2 2022 and held it in 6 quarters. The position peaked at $231K in Q2 2023. 1 fund tracked by Wall St. Rank holds PNT as of Q4 2023.

Principal Financial Group reported no remaining POINT Biopharma Global Inc. Common Stock position as of Q4 2023 after selling out during the quarter.
Principal Financial Group sold 30,000 POINT Biopharma Global Inc. Common Stock shares in Q4 2023, an estimated $200K.
Principal Financial Group first reported a position in POINT Biopharma Global Inc. Common Stock in Q2 2022 and held it in 6 quarters.
Principal Financial Group's POINT Biopharma Global Inc. Common Stock position peaked at $231K in Q2 2023.
1 fund tracked by Wall St. Rank held POINT Biopharma Global Inc. Common Stock as of Q4 2023.

Based on Principal Financial Group's 13F filing for Q4 2023, filed 7 Feb 2024.